Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10144730 Inhibitors of c-Jun-

Patent 10144730 was granted and assigned to Dana-Farber Cancer Institute on December, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Tinghu Zhang0

Nathanael Gray0

Date of Patent

December 4, 2018

0

Patent Application Number

151885450

Date Filed

June 21, 2016

0

Patent Citations Received

US Patent 10787436 Inhibitors of cyclin-dependent kinase 7 (CDK7)

US Patent 10870651 Inhibitors of cyclin-dependent kinase 7 (CDK7)

US Patent 10981903 Inhibitors of c-Jun-N-terminal kinase (JNK)

US Patent 10906889 Polycyclic inhibitors of cyclin-dependent kinase 7 (CDK7)

US Patent 11325910 Inhibitors of cyclin-dependent kinases

US Patent 11040957 Heteroaromatic compounds useful for the treatment of proliferative diseases

US Patent 10550121 Inhibitors of cyclin-dependent kinases

0

US Patent 10702527 Combination therapy of transcription inhibitors and kinase inhibitors

...

Patent Primary Examiner

Alexander R Pagano

0

Patent abstract

The present invention provides novel compounds according to Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10144730 Inhibitors of c-Jun-

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool